Hidetomo Kitamura

This inventor holds 17 USPTO granted patents and 2 published patent applications, plus 5 CIPO patents and 5 EPO patents. Top assignees: Chugai Seiyaku Kabushiki Kaisha, Kazuwa Nakao, Other. Active years: 2002-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hidetomo Kitamura. Retrieved from https://idiyas.com/inventor/hidetomo-kitamura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 2)

% Patents Active = 70.6

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 11)

Average Co-Inventor Count = 3.5

ph-index = 7

Forward Citations = 235(Granted Patents)

Location History:

Shizuoka-ken, JP (2006)
Gotenba, JP (2002 - 2014)
Shizuoka, JP (2013 - 2023)
Gotemba, JP (2024)

Company Filing History:

16 out of 985

Chugai Seiyaku Kabushiki Kaisha

2 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12441804 - Pharmaceutical composition for prevention and/or treatment of atopic dermatitis comprising IL-31 antagonist as active ingredient (2025-10-14),

2. 12077577 - Polypeptide comprising aggrecan binding domain and carrying moiety (2024-09-03),

3. 11773173 - Pharmaceutical composition for prevention and/or treatment of atopic dermatitis comprising IL-31 antagonist as active ingredient (2023-10-03),

4. 10544227 - Pharmaceutical composition for prevention and/or treatment of atopic dermatitis comprising IL-31 antagonist as active ingredient (2020-01-28),

5. 9993462 - Hydantoin derivative-containing pharmaceutical composition (2018-06-12),

6. 9745378 - Antibodies that bind to cytokine receptor NR10 (2017-08-29),

7. 9028821 - Method of treating an inflammatory disease comprising administering an NR 10 antibody antagonist (2015-05-12),

8. 8815803 - Method for increasing body height comprising systemic administration of CNP-53 (2014-08-26),

9. 8658373 - Method of screening for an agent for treating arthritis and promoting growth of articular chondrocytes (2014-02-25),

10. 8597644 - Method for treating psoriasis by administering an antibody to interleukin-6 receptor (2013-12-03),

11. 8562990 - Method of treating psoriatic arthritis with an IL-6 receptor antibody (2013-10-22),

12. 8431127 - Method for treating pruritus comprising administering an NR10 antagonist (2013-04-30),

13. 7642243 - Method of treating arthritis and promoting growth of articular chondrocytes (2010-01-05),

14. 7320792 - Preventives or remedies for psoriasis containing as the active ingredient IL-6 antagonist (2008-01-22),

15. 7037717 - Cell line and screening method with the use of the same (2006-05-02),

Title: The Innovative Journey of Hidetomo Kitamura

Introduction: Hidetomo Kitamura, a pioneering inventor hailing from Shizuoka, Japan, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Kitamura's latest patents include a cutting-edge robotics technology for industrial automation, a revolutionary medical device for minimally invasive surgeries, and a sustainable energy solution for renewable power generation.

Career Highlights: With a career spanning over two decades, Kitamura has established himself as a leading figure in the field of innovation. He has worked with top research institutions and universities to develop cutting-edge technologies that have reshaped various industries.

Collaborations: Throughout his career, Kitamura has collaborated with renowned companies, such as tech giants, leading medical device manufacturers, and innovative startups. His collaborative efforts have led to the successful commercialization of several groundbreaking inventions.

Conclusion: Hidetomo Kitamura's relentless pursuit of innovation and his passion for creating transformative technologies have solidified his position as a visionary inventor in the global landscape of inventions and patents.

Profile summary based on public USPTO records.